Additionally, the source of TGF-β can be diverse (tumor, Tregs, macrophages, MDSCs, etc.)and the heterogeneity of infiltrating immune cells could proportionately alter TGF-β concentrations within tumor models and increase NK cell dysfunction. The gene discussed is TGFB1; the disease is neoplasm.